Alnylam (ALNY) PT Raised to $205 at Oppenheimer, Shares Look Attractive Into 2022 Business and Catalysts
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $205.00 (from $200.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
